Jaguar reports promising results for crofelemer in rare diseases#Jaguar #reports #promising #results #crofelemer #rare #diseases
Tag: Diseases
Gilead, LEO Pharma partner to develop programs for inflammatory diseases By Reuters
(Reuters) – Gilead Sciences (NASDAQ:) said on Saturday that it entered into a partnership with Denmark’s…
Gilead and LEO Pharma Enter Into Strategic Partnership to Accelerate Development of Oral STAT6 Program With Potential in Multiple Inflammatory Diseases
— Strategic Partnership Strengthens Gilead’s Inflammation Research Portfolio with the Addition of LEO Pharma’s Preclinical Oral…